ICON

ICON’s leadership and performance in phase 1 clinical trials recognised in independent industry benchmarking report

Dublin, Ireland – 16 July 2025: ICON plc, a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 clinical trials in a benchmarking report from the independent pharmaceutical market research company Industry Standard Research (ISR). ICON outpaced the average phase 1 performance...

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

4 March 2025 -- Pennsylvania, US and Dublin, Ireland -- Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc, a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link. ICON will utilize Mural Link’s innovative functionality related to clinical...
South County Business Park, Leopardstown, Dublin 18, Ireland

+353 (1) 291 2000